Peter Brooks
Impact in
- Pharmacology top 0.01%
- Musculoskeletal pain and rehabilitation
- Inflammatory mediators and NSAID effects
- Rheumatology top 0.05%
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
Papers in
- Rheumatology 167
- Rheumatoid Arthritis Research and Therapies 115
- Systemic Lupus Erythematosus Research 49
- Osteoarthritis Treatment and Mechanisms 23
- Pharmacology 95
- Inflammatory mediators and NSAID effects 60
- Musculoskeletal pain and rehabilitation 24
- Co-authors
- Rachelle Buchbinder (11 shared papers)Fiona Blyth (10 shared papers)Damian Hoy (7 shared papers)Lyn March (38 shared papers)Anthony D. Woolf (13 shared papers)Theo Vos (6 shared papers)Gail Williams (2 shared papers)Christopher J Bain (2 shared papers)
- Journals
- The Medical Journal of Australia (66 papers)Lara D. Veeken (32 papers)Annals of the Rheumatic Diseases (23 papers)British Journal of Clinical Pharmacology (18 papers)The Journal of Rheumatology (17 papers)
- Partner nations
- AustraliaUnited KingdomUnited States
In The Last Decade
Peter Brooks
567 papers receiving 60.1k citations
Peter Brooks's Hit Papers
Peers
Comparison fields: 5 of 237
- Pharmacology 10.2k
- Rheumatology 7.5k
- Pathology and Forensic Medicine 4.7k
- Psychiatry and Mental health 3.4k
- Health, Toxicology and Mutagenesis 3.2k
Countries citing papers authored by Peter Brooks
This map shows the geographic impact of Peter Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brooks more than expected).
Fields of papers citing papers by Peter Brooks
This network shows the impact of papers produced by Peter Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brooks. The network helps show where Peter Brooks may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Brooks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 626 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 9757 |
| 2 | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 7189 |
| 3 | Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 Hit paper breakdown → | 2012 | 6758 |
| 4 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Hit paper breakdown → | 2015 | 5317 |
| 5 | The global burden of low back pain: estimates from the Global Burden of Disease 2010 study Hit paper breakdown → | 2014 | 2476 |
| 6 | A systematic review of the global prevalence of low back pain Hit paper breakdown → | 2012 | 2332 |
| 7 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 Hit paper breakdown → | 2015 | 2272 |
| 8 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition Hit paper breakdown → | 2015 | 1615 |
| 9 | The Epidemiology of low back pain Hit paper breakdown → | 2010 | 1518 |
| 10 | Reading for the plot : design and intention in narrative Hit paper breakdown → | 1984 | 1072 |
| 11 | Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2023 | 1055 |
| 12 | American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials Hit paper breakdown → | 2011 | 883 |
| 13 | Nonsteroidal Antiinflammatory Drugs — Differences and Similarities Hit paper breakdown → | 1991 | 669 |
| 14 | Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0 Hit paper breakdown → | 2014 | 668 |
| 15 | American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials Hit paper breakdown → | 2011 | 661 |
| 16 | Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. Hit paper breakdown → | 1997 | 637 |
| 17 | The global burden of neck pain: estimates from the Global Burden of Disease 2010 study Hit paper breakdown → | 2014 | 581 |
| 18 | 2006 | 460 | |
| 19 | 2007 | 447 | |
| 20 | The burden of musculoskeletal conditions at the start of the new millennium | 2003 | 437 |
About Peter Brooks
Peter Brooks is a scholar working on Rheumatology, Pharmacology, Rehabilitation, Hematology and General Health Professions, having authored 626 papers that have together received 64.7k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (115 papers), Inflammatory mediators and NSAID effects (60 papers), Systemic Lupus Erythematosus Research (49 papers), Musculoskeletal Disorders and Rehabilitation (40 papers), Primary Care and Health Outcomes (29 papers), Autoimmune and Inflammatory Disorders Research (26 papers), Musculoskeletal pain and rehabilitation (24 papers) and Osteoarthritis Treatment and Mechanisms (23 papers). The work is most often cited by research in Pharmacology (10.2k citations), Rheumatology (7.5k citations), Pathology and Forensic Medicine (4.7k citations), Psychiatry and Mental health (3.4k citations) and Health, Toxicology and Mutagenesis (3.2k citations). Peter Brooks has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Rachelle Buchbinder, Fiona Blyth, Damian Hoy, Lyn March, Anthony D. Woolf, Theo Vos, Gail Williams, Christopher J Bain, Richard Osborne Day and Emma U.R. Smith. Their work appears in journals such as The Medical Journal of Australia, Lara D. Veeken, Annals of the Rheumatic Diseases, British Journal of Clinical Pharmacology and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.